Consistent with the observed relationship between IL-13Rα1 expression and ACC survival, the age at death was also significantly higher in patients with medium (58.76 years) or high (62.33 year) versus low (34.76 years) IL-13Rα1 expression. This evidence concerns the gene IL13RA1 and adrenal cortex carcinoma.